6:13 PM
 | 
May 15, 2015
 |  BC Extra  |  Company News

Sorrento rises on NantWorks deal

Sorrento Therapeutics Inc. (NASDAQ:SRNE) gained $1.51 (13%) to $13.01 on news that its Igdrasol Inc. subsidiary will be acquired by Patrick Soon-Shiong's NantWorks LLC (Los Angeles, Calif.) for $90 million up front.

The acquisition will include Cynviloq, an injectable nanoparticle formulation of paclitaxel that is...

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >